Allozymes Secures $15M to Revolutionize Industries.

 

Allozymes, a pioneer in enzyme discovery and engineering, has announced the completion of a $15 million Series A funding round. The funding was led by Seventure Partners of France and Xora Innovation of Singapore, highlighting the growing recognition of Allozymes' potential. This investment will accelerate the company's expansion into Europe and establish strategic partnerships in the food, chemical, pharmaceutical, and life science industries. Moreover, the funding will support the development of a comprehensive enzyme data library for future discoveries. New investors, including NUS Technology Holdings and Thia Ventures, have joined the round, while existing investors SOSV and Entrepreneur First have continued their support. Allozymes' core technology, the proprietary microfluidic platform, enables rapid enzyme screening, analyzing over 20 million variants per day. This platform significantly increases the chances of successfully developing custom enzymes for specific industrial applications.

More Information : https://www.techdogs.com/tech-news/pr-newswire/allozymes-raises-15-million-in-series-a-funding-poised-to-revolutionize-industries-with-enzymatic-solutions

Comments

Popular posts from this blog

Aon Unveils $350M Program for Ukraine Recovery

E&R Engineering Debuts Advanced Solutions at Semicon SEA 2024

Cloud Computing Trends 2025